Medtronic (MDT) Tops Q1 EPS by 1c; Offers FY23 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- Arm Holdings falls as CFO stock sale weighs on sentiment
Medtronic (MDT) Downgraded by Raymond James on Growing Impatience
August 24, 2022 12:31 PM EDTShares of Medtronic (NYSE: MDT) were downgraded to Market Perform from Outperform by Raymond James analyst Jayson Bedford on Wednesday, stating that the firm is "growing impatient."
Bedford downgraded the stock following its fiscal Q1 earnings release on Tuesday, stating the company's... More
